DK172927B1 - Aryl-heteroarylcarbinolderivater, fremgangsmåder til fremstilling af heraf og farmaceutiske præparater indeholdende ovennæv - Google Patents

Aryl-heteroarylcarbinolderivater, fremgangsmåder til fremstilling af heraf og farmaceutiske præparater indeholdende ovennæv Download PDF

Info

Publication number
DK172927B1
DK172927B1 DK198801701A DK170188A DK172927B1 DK 172927 B1 DK172927 B1 DK 172927B1 DK 198801701 A DK198801701 A DK 198801701A DK 170188 A DK170188 A DK 170188A DK 172927 B1 DK172927 B1 DK 172927B1
Authority
DK
Denmark
Prior art keywords
methyl
methanol
dimethylamino
ethyl
imidazol
Prior art date
Application number
DK198801701A
Other languages
Danish (da)
English (en)
Other versions
DK170188D0 (da
DK170188A (da
Inventor
Augusto Colombo
Juan Pares
Jordi Frigola
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of DK170188D0 publication Critical patent/DK170188D0/da
Publication of DK170188A publication Critical patent/DK170188A/da
Application granted granted Critical
Publication of DK172927B1 publication Critical patent/DK172927B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198801701A 1987-04-10 1988-03-28 Aryl-heteroarylcarbinolderivater, fremgangsmåder til fremstilling af heraf og farmaceutiske præparater indeholdende ovennæv DK172927B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8705118A FR2613720B1 (fr) 1987-04-10 1987-04-10 Derives d'aryl-heteroaryl carbinols avec activite analgesique
FR8705118 1987-04-10

Publications (3)

Publication Number Publication Date
DK170188D0 DK170188D0 (da) 1988-03-28
DK170188A DK170188A (da) 1988-10-11
DK172927B1 true DK172927B1 (da) 1999-10-04

Family

ID=9350010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801701A DK172927B1 (da) 1987-04-10 1988-03-28 Aryl-heteroarylcarbinolderivater, fremgangsmåder til fremstilling af heraf og farmaceutiske præparater indeholdende ovennæv

Country Status (12)

Country Link
US (1) US5017596A (de)
EP (1) EP0289380B1 (de)
JP (1) JPH0651678B2 (de)
KR (1) KR930009442B1 (de)
AT (1) ATE116303T1 (de)
BR (1) BR1100931A (de)
DE (1) DE3852565T2 (de)
DK (1) DK172927B1 (de)
ES (1) ES2014523A6 (de)
FR (1) FR2613720B1 (de)
GR (1) GR3015616T3 (de)
PT (1) PT87183B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681322B1 (fr) * 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
WO1995029898A1 (en) * 1994-05-02 1995-11-09 Zeneca Limited Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2245226B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
JP2007531785A (ja) * 2004-04-05 2007-11-08 ラボラトリオス・デル・デエレ・エステベ・エセ・ア 活性物質組合せ物
EP1584335A3 (de) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Zusammensetzung aus Aktiva mit einer Carbinolverbindung und einem Opioid
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1632227A1 (de) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Aryl- (oder Heteroaryl-) Azolcarbinole (insbesondere Cizolirtin Citrate) für die Behandlung von Opioid Abhängigkeit
EP1671968A1 (de) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Verfahren zur Herstellung von Enantiomeren von Thienylazolylalkoxyethanamines
EP1671953A1 (de) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Verfahren zur Herstellung von Cizolirtine und dessen Enantiomeren
EP1674465A1 (de) 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Verfahren zur Gewinnung der Enatiomeren der Thienylazolylalkoxyethanaminen
WO2006087147A2 (en) * 2005-02-15 2006-08-24 Laboratorios Del Dr. Esteve, S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia
EP1690537A1 (de) * 2005-02-15 2006-08-16 Laboratorios Del Dr. Esteve, S.A. Aryl-(oder Heteroaryl-) Azolylcarbynolderivative zur Behandlung von Fibromyalgie
EP1695704A1 (de) * 2005-02-28 2006-08-30 Laboratorios Del Dr. Esteve, S.A. Aryl- (oder Heteroaryl-) Azolylcarbynolderivative zur Behandlung von Fibromyalgie
ES2286920B1 (es) * 2005-02-15 2008-08-16 Laboratorios Del Dr. Esteve, S.A. Derivados de aril (o heteroaril)azolilcarbinoles para el tratamiento de la fibromialgia.
EP1743890A1 (de) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-Pyrazol-Derivative, Verfahren zur Herstellung und ihre Verwendung als Medikamente.
EP1743892A1 (de) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituierte Pyrazolin Verbindungen, deren Herstellung und Verwendung als Medikament
EP1757587A1 (de) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituierte Pyrazolinderivate, ihre Herstellung und Verwendung als Arzneimittel
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
EP1820502A1 (de) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Wirkstoffzusammensetzungen enthaltend Azolycarbinolderivate
EP2151234A1 (de) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmazeutische Formulierung mit einer CB1-Rezeptorverbindung in einer festen Lösung und/oder festen Dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
JPS5118950B2 (de) * 1972-06-30 1976-06-14
US4853404A (en) * 1986-10-13 1989-08-01 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives composition and use

Also Published As

Publication number Publication date
EP0289380A1 (de) 1988-11-02
DK170188D0 (da) 1988-03-28
EP0289380B1 (de) 1994-12-28
US5017596A (en) 1991-05-21
BR1100931A (pt) 1999-11-23
GR3015616T3 (en) 1995-06-30
JPS63267761A (ja) 1988-11-04
ATE116303T1 (de) 1995-01-15
JPH0651678B2 (ja) 1994-07-06
FR2613720A1 (fr) 1988-10-14
DE3852565D1 (de) 1995-02-09
PT87183A (pt) 1988-05-01
DE3852565T2 (de) 1995-05-11
FR2613720B1 (fr) 1990-01-19
KR930009442B1 (ko) 1993-10-04
KR880012558A (ko) 1988-11-28
ES2014523A6 (es) 1990-07-16
PT87183B (pt) 1992-08-31
DK170188A (da) 1988-10-11

Similar Documents

Publication Publication Date Title
DK172927B1 (da) Aryl-heteroarylcarbinolderivater, fremgangsmåder til fremstilling af heraf og farmaceutiske præparater indeholdende ovennæv
EP2547664B1 (de) Morpholinylchinazoline
US10544126B2 (en) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
AU2013366513B2 (en) Novel benzimidazole derivatives as kinase inhibitors
US8153630B2 (en) Kinase inhibitors
US20080004263A1 (en) Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
SA517380651B1 (ar) مثبطات ديميثيلاز-1 خاص بلايسين
EP2167491A1 (de) 5-heteroaryl-substituierte indazole als kinaseinhibitoren
TW200930370A (en) Hedgehog pathway antagonists and therapeutic applications thereof
JP2006511571A (ja) ピラゾール化合物
US20200308165A1 (en) Compounds as Ras Inhibitors and Use Thereof
CA2521201A1 (en) Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors
AU2006237920A1 (en) Nitrogen-containing heterocyclic compound
US8987310B2 (en) Heterocycle amide T-type calcium channel antagonists
WO2019136147A1 (en) Toll-like receptor signaling inhibitors
TW201208679A (en) Sigma receptor inhibitors
TW200808769A (en) Therapeutic compounds
JP2009508818A (ja) 5−HT2C受容体アゴニストとしての6−置換−2,3,4,5−テトラヒドロ−1H−ベンゾ[d]アゼピン
AU2009266756B2 (en) Triazole derivative or salt thereof
WO2015052283A1 (en) Diarylalkylamine rev-erb antagonists and their use as medicaments
WO2017160069A1 (ko) 신규한 벤젠설폰아미드 유도체 및 이의 용도
KR20140025326A (ko) 신규 인돌, 인다졸 유도체 또는 그 염
CZ9302010A3 (en) DERIVATIVE OF 4-AMINO-1,3,4,5/TETRAHYDROBENZ(cd)INDOLE SUBSTITUTED IN POSITION 6 BY A HETEROCYCLIC GROUP, PROCESS OF ITS PREPARATION AND A PHARMACEUTICAL PREPARATION IN IT IS COMPRISED
NZ541544A (en) Benzimidazole derivatives and their use for modulating the GABAA receptor complex
US8119812B2 (en) Thiazolidinone derivative

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
B1 Patent granted (law 1993)
PUP Patent expired